Krka dd Novo Mesto Clinical Trials
Determine Krka dd Novo Mesto go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Krka dd Novo Mesto Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| Comparative Pharmacokinetic Study of the Bioequivalence of the Investigational Medicinal Product Amlodipine+indapamide+perindopril (10 mg+2.5 mg+10 mg, Tablets, Jsc Krka, D.d., Novo Mesto, Slovenia) and the Reference Medicinal Product Triplixam (Amlodipine+indapamide+ Perindopril, 10 mg + 2.5 mg + 10 mg, Film-coated Tablets, Laboratories Servier, France) After a Single Oral Dose of the Drug in Healthy Male Volunteers on an Empty Stomach | GDCT0466375 | (perindopril + indapamide + amlodipine) | Cardiovascular | Idiopathic (Essential) Hypertension | Phase I | Planned | Krka dd Novo Mesto |
| Comparative Pharmacokinetic Study of the Bioequivalence of the Investigational Medicinal Product Valsartan + Indapamide (160 Mg + 1.5 Mg, Modified Release Tablets, Jsc Krka D.D., Novo Mesto, Slovenia) and the Reference Medicinal Products Arifon Retard (Indapamide, 1.5 Mg , Extended-release Film-coated Tablets, Laboratories Servier, France) and Diovan (Valsartan, 160 Mg, Film-coated Tablets, Novartis Pharma Ag, Switzerland) after a Single Oral Dose of the Drug in Healthy Male and Female Volunteers on an Empty Stomach | GDCT0465415 | (indapamide + valsartan) MR | Cardiovascular | Cardiovascular Risk Factors; Chronic Heart Failure; Congestive Heart Failure (Heart Failure); Hypertension; Idiopathic (Essential) Hypertension; Left Ventricular Dysfunction; Myocardial Infarction; Post-Myocardial Infarction | Phase I | Planned | Krka dd Novo Mesto |
| Comparative Pharmacokinetic Study of the Bioequivalence of the Investigational Medicinal Product Telmisartan + Amlodipine + Hydrochlorothiazide (80 Mg + 10 Mg + 12.5 Mg, Tablets, Jsc Krka D.D., Novo Mesto, Slovenia) and the Reference Medicinal Products Micardisplus (Telmisartan + Hydrochlorothiazide, 80 Mg + 12.5 Mg, Tablets, Boehringer Ingelheim Inter Gmbh, Germany) and Norvasc (Amlodipine, 10 Mg, Tablets, Upjohn Ues 1 Lelsi, Usa) after a Single Oral Administration of the Drug to Healthy Male Volunteers on an Empty Stomach | GDCT0464092 | (amlodipine + hydrochlorothiazide + telmisartan) | Cardiovascular | Angina (Angina Pectoris); Chronic Stable Angina; Coronary Artery Disease (CAD) (Ischemic Heart Disease); Hypertension; Idiopathic (Essential) Hypertension; Myocardial Ischemia; Prinzmetal Angina (Variant Angina/Vasospastic Angina); Refractory Angina; Stable Angina | Phase I | Planned | Krka dd Novo Mesto |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer